FRESENIUS MEDICAL CARE AND QUEST DIAGNOSTICS AGREED TO A DEAL in which Quest will provide laboratory testing services for the latter’s dialysis clinics in the United States. Separately, Quest Diagnostics will acquire “select assets” of Spectra Laboratories, a wholly owned FMC subsidiary that currently provides those services. FMC is one of the two dominant providers […]
Quest Acquires ‘Select Assets’ of Fresenius Medical Care
Economies of scale were a major factor in this agreement involving testing for dialysis patients
- By Robert Michel
- > From the Volume XXXII, No. 4 - March 10, 2025 Issue
- Tags: American Kidney Fund, American Society of Nephrology, CDC, Christopher Jahnle, COVID-19, DaVita, dialysis, end stage renal disease, ESRD Prospective Payment System, FedEx, FMC, Fresenius Medical Care, Haverford Healthcare Advisors, Helen Giza, immunocompromised, kidney failure, Medical laboratory, Medicare, Medicare Advantage, National Kidney Foundation, New York Stock Exchange, pandemic, Pathology, Quest Diagnostics, Spectra Laboratories, the dark report, U.S. Centers for Disease Control and Prevention
